[ad_1] U.Ozel.Images/E+ by way of Getty Images Although different corporations are poised to have GLP-1 receptor agonist medication for weight loss authorized, they don’t seem to…
[ad_1] travellinglight/iStock by way of Getty Images Shortly after a U.Okay. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s…
